CHICAGO, Dec. 2, 2024 /PRNewswire/ — Neusoft Medical Systems Co., Ltd. (“Neusoft Medical Systems”), a global leader in medical imaging solutions and services, is proud to announce its participation in the Radiological Society of North America (RSNA) 2024 Annual Meeting, taking place in Chicago from December 1-5.
RSNA is the world’s premier scientific and educational event for the radiological sciences, bringing together leading professionals from around the globe. At this year’s meeting, Neusoft Medical Systems is showcasing its cutting-edge portfolio of AI-powered medical imaging technologies designed to enhance diagnostic precision, streamline clinical workflows, and expand access to quality care globally.
“At Neusoft Medical Systems, we empower radiologists to address clinical challenges while enhancing the accessibility and affordability of medical imaging for regions and communities in need,” said Patrick Wu, CEO of Neusoft Medical Systems. “By integrating advanced medical imaging, artificial intelligence, and clinical expertise, we aim to provide caregivers with comprehensive tools for accurate diagnoses. We look forward to engaging with industry leaders at RSNA 2024 to further advance healthcare through innovation.”
The booth features a variety of groundbreaking innovations, including:
For further information, please visit www.neusoftmedical.com/en
About Neusoft Medical Systems
Neusoft Medical Systems Co., Ltd. is a global leader in medical imaging solutions and services, delivering intelligent, efficient, precise, and secure products to customers worldwide. Serving over 13,000 medical institutions in 110+ countries, the company has installed more than 47,000 units globally, covering diverse categories, grades, and customer segments.
* Not all equipment models and services featured in this press are available in every region of the world.
SOURCE Neusoft Medical Systems Co., Ltd.
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…